Barchart.com
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Enlivex Therapeutics Ltd (ENLV)

Enlivex Therapeutics Ltd (ENLV)
0.8500 -0.0100 (-1.16%) 14:51 ET [NASDAQ]
0.8415 x 1 0.8600 x 31
Realtime by (Cboe BZX)
0.8415 x 1 0.8600 x 31
Realtime - - (-) -
News & Headlines for Wed, Apr 16th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
RedChip Announces Webinar to Teach Investors How to Use RedChat, a Revolutionary AI Chatbot for Small-Cap Stock Analysis ACCESS Newswire - Tue Feb 11, 8:30AM CST

Unlock AI-powered insights for data-driven precision and real-time efficiency

ENLV : 0.8500 (-1.16%)
ASPI : 5.87 (+3.16%)
BFRG : 1.6900 (+1.81%)
NVA : 12.97 (+0.15%)
GRRR : 19.33 (+1.10%)
The Trump Effect: Crypto Diversification Accelerates Across Industries BayStreet.ca - Thu Jan 16, 8:16AM CST

Issued on behalf of Spearmint Resources Inc. VANCOUVER – USA News Group – With the upcoming inauguration of US President Re-Elect Donald Trump on the horizon, several businesses are diversifying...

MSTR : 316.73 (+1.63%)
TSLA : 239.57 (-0.82%)
ENLV : 0.8500 (-1.16%)
SPMTF : 0.0124 (+13.76%)
SPMT.CN : 0.0150 (unch)
^BTCUSDT : 84,706.04 (+0.51%)
HOTH : 0.7999 (+3.37%)
^BTCUSD : 84,789.71 (+0.58%)
Enlivex Therapeutics and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV ACCESS Newswire - Fri Jan 10, 3:00AM CST

ORLANDO, FL / ACCESSWIRE / January 10, 2025 / RedChip Companies will air interviews with Enlivex Therapeutics Ltd. (Nasdaq:ENLV) and bioAffinity Technologies, Inc. (Nasdaq:BIAF) on the RedChip Small Stocks,...

ENLV : 0.8500 (-1.16%)
BIAF : 0.5227 (+11.31%)
Enlivex Therapeutics Ltd. Receives Approval for Phase I Trial of Allocetra™ in TMJ Osteoarthritis Patients Quiver Quantitative, Inc. - Wed Dec 11, 2024

Enlivex Therapeutics received authorization for a Phase I trial of Allocetra™ for TMJ osteoarthritis in Israel.Quiver AI SummaryEnlivex Therapeutics Ltd. has received approval from the Israeli Ministry...

ENLV : 0.8500 (-1.16%)
Join Enlivex Therapeutics' Exclusive Live Investor Webinar and Q&A Session on December 3 ACCESS Newswire - Tue Nov 26, 2024

NESS ZIONA, ISRAEL / ACCESSWIRE / November 26, 2024 / Enlivex Therapeutics Ltd. (Nasdaq:ENLV)(the "Company"), a clinical-stage macrophage reprogramming immunotherapy company, is pleased to invite investors...

ENLV : 0.8500 (-1.16%)
Enlivex Therapeutics Ltd. Approves Purchase of Up to $1 Million in Bitcoin as Part of Cash Management Strategy Quiver Quantitative, Inc. - Wed Nov 20, 2024

Enlivex Therapeutics plans to purchase $1 million in Bitcoin to diversify its treasury reserves amid increasing demand.Quiver AI SummaryEnlivex Therapeutics Ltd., a clinical-stage company focused on macrophage...

ENLV : 0.8500 (-1.16%)
New Strong Buy Stocks for October 23rd
New Strong Buy Stocks for October 23rd Zacks Investment Research - Wed Oct 23, 2024

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Rent the Runway, Inc. RENT: This designer clothing rental company has seen the Zacks Consensus Estimate for its current year earnings...

ENLV : 0.8500 (-1.16%)
PTON : 5.40 (-3.91%)
GTEC : 1.4685 (+1.98%)
DSGR : 26.44 (+1.61%)
RENT : 4.18 (+2.70%)
CREA Stats, U.S. Retail Sales Featured Next Week Baystreet - Fri Jun 14, 2024

Monday U.S. Featured Earnings Lennar Corp. (NYSE: LEN) (Q2) EPS of $3.20, compared to $2.94 ...

DLNG : 3.44 (-1.14%)
SCS : 9.75 (+0.41%)
ASTL.TO : 6.69 (+2.45%)
DDD : 1.8300 (-5.18%)
PDCO : 31.33 (+0.03%)
KR : 71.43 (+3.51%)
ET.TO : 10.55 (-0.85%)
CRMT : 47.62 (+1.45%)
KBH : 51.47 (+2.63%)
ENLV : 0.8500 (-1.16%)
LEN : 104.35 (+1.55%)
FDS : 429.23 (+0.47%)
Enlivex Receives Notice of Allowance for U.S. Patent Application Covering Methods of Treating Sepsis with Allocetra™ Globe Newswire - Wed Aug 3, 2022

Nes-Ziona, Israel, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming...

ENLV : 0.8500 (-1.16%)
Sheba Medical Center and Enlivex Announce Dosing of the First Patient in Phase I/II Trial Evaluating Allocetra Combined with Chemotherapy in Patients with Peritoneal Metastases Arising from Solid Cancers Globe Newswire - Wed Jul 6, 2022

First clinical trial of Allocetra™ in patients with cancer builds upon promising preclinical studies demonstrating its broadly applicable immunotherapeutic...

ENLV : 0.8500 (-1.16%)

Barchart Exclusives

Is Silver Back on a Bullish Path? Barchart - 23 minutes ago
Silver is twice as volatile as gold, making it a highly speculative asset. In March, silver prices looked like they were heading for a test of the 2011 and 1980 highs, but April has been another story. Silver’s exclusion from tariffs caused a tidal wave of selling from April 2 through April 7. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro
Wed, Apr 23, 2025 5:00 PM UTC
Reserve Your Spot